KT&G Reports Strong Second Quarter Financial Performance in 2024

Business by 2FIRSTS.ai
Aug.08.2024
KT&G Reports Strong Second Quarter Financial Performance in 2024
KT&G announced record-breaking Q2 financial results, driven by strong overseas tobacco sales growth, aiming to become a global leader.

According to a report from the American Broadcasting Company on August 8th, South Korean tobacco manufacturer KT&G (KRX: 033780) held a financial results conference call today and announced their second quarter financial performance ending on June 30, 2024. The company reported a total revenue of 1.424 trillion Korean won (approximately 1.03 billion US dollars) and an operating profit of 321.5 billion Korean won (approximately 230 million US dollars), representing year-on-year growth of 6.6% and 30.6% respectively.

 

The main driver of this growth was a strong performance in the overseas tobacco business, which is one of the company's three core growth businesses. The overseas tobacco business saw growth in all key indicators such as revenue, operating profit, and sales volume, with revenue reaching a record-breaking 359.1 billion Korean won (approximately 260 million US dollars), representing a 35.3% year-on-year increase, and operating profit increasing by 139.1% year-on-year.

 

Domestic (South Korea) new tobacco product business ("NGP") achieved growth in key indicators such as revenue, operating profit, and sales volume, with year-on-year increases of 10.8%, 42.8%, and 7.7% respectively. Thanks to the increase in sales volume of HNB tobacco products, the profitability of overseas business continues to improve.

 

KT&G has announced that it aims to accelerate its vision of becoming a "global top-tier" company by strengthening the fundamental competitiveness of its core growth businesses and implementing structural reforms. To achieve this, the company has signed a cooperation memorandum with Philip Morris International in July to jointly submit a pre-market tobacco product application (PMTA) for KT&G's next generation HNB tobacco products.

 

During the financial report conference call, KT&G mentioned that the company expects a 2.5-3% increase in annual consolidated revenue, while operating profit will remain flat due to changes in the business environment for health functional foods and real estate sectors.

 

A spokesperson for KT&G stated:

 

In the second quarter, we achieved growth in revenue and operating profit through expanding our overseas business. We will continue to strengthen the competitiveness of our core growth businesses, maximize company value, and enhance shareholder value through a best-in-class shareholder return policy.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
Nova Scotia, Canada: 16% of Residents Vape; Local E-Liquids and Disposable Products in High Demand
The latest data show that in 2024, disposable vape sales in Nova Scotia grew by 25%, and about 16% of residents use vaping products—signaling strong demand for tobacco alternatives. The province’s regulatory framework is forcing retailers to accelerate product-line adjustments and compliance upgrades.
Sep.23 by 2FIRSTS.ai
Chill Brands acquires UK exclusive distribution rights for ELF nicotine pouches, also distributing ELFBAR and Lost Mary e-cigarettes
Chill Brands acquires UK exclusive distribution rights for ELF nicotine pouches, also distributing ELFBAR and Lost Mary e-cigarettes
Chill Brands Group has partnered with ELF Nicotine Pouches, appointing as its master distributor in the UK. Products will be distributed through the Chill Connect channel. All items are manufactured by Shenzhen iMiracle Technology, which also produces ELFBAR and Lost Mary e-cigarettes. The agreement covers distribution of ELF nicotine pouches, ELFBAR, and Lost Mary products across UK convenience stores.
Sep.11 by 2FIRSTS.ai
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
A new study shows that flavored e-cigarettes, even without nicotine, can interfere with embryo implantation and placental development, increasing the risks of miscarriage and fetal growth restriction, underscoring their potential threat to pregnancy safety.
Sep.01 by 2FIRSTS.ai
Vapeitalia Partners with UK E-Liquid Brand Vampire Vape to Launch Exclusive Flavors and New Product Line in Italy
Vapeitalia Partners with UK E-Liquid Brand Vampire Vape to Launch Exclusive Flavors and New Product Line in Italy
UK e-liquid brand Vampire Vape is entering the Italian market through an exclusive partnership with Vapeitalia. The collaboration will introduce the brand’s signature flavors Heisenberg and Pinkman, along with the new Purple Craze Ice. At the same time, Vampire Vape’s Bar Salts range will make its Italian debut, offering users a diverse selection of fruit flavors.
Aug.29 by 2FIRSTS.ai
UK Vaping Product Approvals Soar to 1,552, a 32x Increase | Pod Products Drive Growth
UK Vaping Product Approvals Soar to 1,552, a 32x Increase | Pod Products Drive Growth
The UK's MHRA database saw a 32-fold increase in e-cigarette registrations from Sep 8-14, with 1,552 new approvals. Pod products from brands like ELFBAR and SMOK made up over 90% of the new entries.
Sep.16 by 2FIRSTS.ai
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai